Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1956 Aug;19(3):232–235. doi: 10.1136/jnnp.19.3.232

A CONTROLLED CLINICAL STUDY OF CHLORPROMAZINE AND RESERPINE IN CHRONIC SCHIZOPHRENIA

Michael Shepherd 1, David C Watt 1
PMCID: PMC497211  PMID: 13357965

Full text

PDF
232

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANTON-STEPHENS D. Preliminary observations on the psychiatric uses of chlorpromazine (largactil). J Ment Sci. 1954 Apr;100(419):543–557. doi: 10.1192/bjp.100.419.543. [DOI] [PubMed] [Google Scholar]
  2. BARSA J. A., KLINE N. S. Treatment of two hundred disturbed psychotics with reserpine. J Am Med Assoc. 1955 May 14;158(2):110–113. doi: 10.1001/jama.1955.02960020016005. [DOI] [PubMed] [Google Scholar]
  3. CAMPDEN-MAIN B. C., WEGIELSKI Z. The control of deviant behavior in chronically disturbed psychotic patients by the oral administration of reserpine. Ann N Y Acad Sci. 1955 Apr 15;61(1):117–122. doi: 10.1111/j.1749-6632.1955.tb42458.x. [DOI] [PubMed] [Google Scholar]
  4. CHARATAN F. B. An evaluation of chlorpromazine ("largacill") in psychiatry. J Ment Sci. 1954 Oct;100(421):882–893. doi: 10.1192/bjp.100.421.882. [DOI] [PubMed] [Google Scholar]
  5. FOOTE E. S. Reserpine in treatment of chronic psychotics; preliminary observations. Br Med J. 1955 May 14;1(4923):1192–1193. doi: 10.1136/bmj.1.4923.1192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. GLYNN J. D. Rauwolfia serpentina (serpasil) in psychiatry. J Neurol Neurosurg Psychiatry. 1955 Aug;18(3):225–227. doi: 10.1136/jnnp.18.3.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. GOLDMAN D. Treatment of psychotic states with chlorpromazine. J Am Med Assoc. 1955 Apr 9;157(15):1274–1278. doi: 10.1001/jama.1955.02950320004002. [DOI] [PubMed] [Google Scholar]
  8. KINROSS-WRIGHT V. Chlorpromazine and reserpine in the treatment of psychoses. Ann N Y Acad Sci. 1955 Apr 15;61(1):174–182. doi: 10.1111/j.1749-6632.1955.tb42464.x. [DOI] [PubMed] [Google Scholar]
  9. LABHARDT F. Die Largactiltherapie bei Schizophrenien und anderen psychotischen Zuständen. Schweiz Arch Neurol Psychiatr. 1954;73(1-2):309–338. [PubMed] [Google Scholar]
  10. LOMAS J., BOARDMAN R. H., MARKOWE M. Complications of chlorpromazine therapy in 800 mental-hospital patients. Lancet. 1955 Jun 4;268(6875):1144–1147. doi: 10.1016/s0140-6736(55)90642-5. [DOI] [PubMed] [Google Scholar]
  11. NOCE R. H., WILLIAMS D. B., RAPAPORT W. Reserpine (serpasil) in the management of the mentally ill. J Am Med Assoc. 1955 May 7;158(1):11–15. doi: 10.1001/jama.1955.02960010013003. [DOI] [PubMed] [Google Scholar]
  12. TASHER D. C., CHERMAK M. W. The use of reserpine in shock-reversible patients and shock-resistant patients. Ann N Y Acad Sci. 1955 Apr 15;61(1):108–116. doi: 10.1111/j.1749-6632.1955.tb42457.x. [DOI] [PubMed] [Google Scholar]
  13. VAUGHAN G. F., LEIBERMAN D. M., COOK L. C. Chlorpromazine in psychiatry. Lancet. 1955 May 28;268(6874):1083–1087. doi: 10.1016/s0140-6736(55)90587-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES